Personal information

Keywords

Medicinal Chemistry, Photopharmacology, GPCR Pharmacology

Countries

Germany, United Kingdom

Activities

Collapse all

Works (11)

Arylazobenzimidazoles: versatile visible-light photoswitches with tuneable Z-isomer stability

Chemical Science
2024 | Journal article
DOI: 10.1039/D3SC05246J
Contributors: Sophie A. M. Steinmüller; Magdalena Odaybat; Giulia Galli; Davia Prischich; Matthew J. Fuchter; Michael Decker
Source: check_circle
Crossref

A MassQL-Integrated Molecular Networking Approach for the Discovery and Substructure Annotation of Bioactive Cyclic Peptides

Journal of Natural Products
2024-04-26 | Journal article
DOI: 10.1021/acs.jnatprod.3c00750
Contributors: Tim Berger; Judith Alenfelder; Sophie Steinmüller; Dominik Heimann; Namrata Gohain; Daniel Petras; Mingxun Wang; Robert Berger; Evi Kostenis; Raphael Reher
Source: check_circle
Crossref

Frontispiece: Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists

Angewandte Chemie International Edition
2023-12-04 | Journal article
DOI: 10.1002/anie.202384961
Contributors: Sophie A. M. Steinmüller; Julia Fender; Marie H. Deventer; Anna Tutov; Kristina Lorenz; Christophe P. Stove; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Frontispiz: Mit sichtbarem Licht schaltbare Benzimidazol‐Azo‐Arene wirken als β‐Arrestin2 funktionell selektive Cannabinoid‐Rezeptor 2 Agonisten

Angewandte Chemie
2023-12-04 | Journal article
DOI: 10.1002/ange.202384961
Contributors: Sophie A. M. Steinmüller; Julia Fender; Marie H. Deventer; Anna Tutov; Kristina Lorenz; Christophe P. Stove; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Mit sichtbarem Licht schaltbare Benzimidazol‐Azo‐Arene wirken als β‐Arrestin2 funktionell selektive Cannabinoid‐Rezeptor 2 Agonisten

Angewandte Chemie
2023-12-04 | Journal article
DOI: 10.1002/ange.202306176
Contributors: Sophie A. M. Steinmüller; Julia Fender; Marie H. Deventer; Anna Tutov; Kristina Lorenz; Christophe P. Stove; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists

Angewandte Chemie International Edition
2023-12-04 | Journal article
DOI: 10.1002/anie.202306176
Contributors: Sophie A. M. Steinmüller; Julia Fender; Marie H. Deventer; Anna Tutov; Kristina Lorenz; Christophe P. Stove; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Bridging the Binding Sites 2.0: Photoswitchable Dualsteric Ligands for the Cannabinoid 2 Receptor

ACS Chemical Neuroscience
2023-10-18 | Journal article
DOI: 10.1021/acschemneuro.3c00509
Contributors: Sophie A. M. Steinmüller; Anna Tutov; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model

Journal of Medicinal Chemistry
2023-05-11 | Journal article
DOI: 10.1021/acs.jmedchem.3c00541
Contributors: Philipp Spatz; Sophie A. M. Steinmüller; Anna Tutov; Eleonora Poeta; Axelle Morilleau; Allison Carles; Marie H. Deventer; Julian Hofmann; Christophe P. Stove; Barbara Monti et al.
Source: check_circle
Crossref

Bridging the Binding Sites: Dualsteric Ligands for the Cannabinoid 2 Receptor (CB2R)

Advanced Therapeutics
2023-04 | Journal article
DOI: 10.1002/adtp.202200260
Contributors: Anna Tutov; Sophie A. M. Steinmüller; Yesid A. Ramírez; Christine E. Jack; Diego A. Rodríguez‐Soacha; Christoph Sotriffer; James N. Hislop; Michael Decker
Source: check_circle
Crossref

Novel benzimidazole-based pseudo-irreversible butyrylcholinesterase inhibitors with neuroprotective activity in an Alzheimer's disease mouse model

RSC Medicinal Chemistry
2022 | Journal article
DOI: 10.1039/d2md00087c
Part of ISSN: 2632-8682
Contributors: Sophie A. M. Steinmüller
Source: Self-asserted source
Sophie A. M. Steinmüller
grade
Preferred source (of 2)‎

Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1) “Cis-On” Agonist

ACS Chemical Neuroscience
2022-07-26 | Journal article
DOI: 10.1021/acschemneuro.2c00160
Part of ISSN: 1948-7193
Part of ISSN: 1948-7193
Contributors: Sophie A. M. Steinmüller
Source: Self-asserted source
Sophie A. M. Steinmüller
grade
Preferred source (of 2)‎
How many people are using ORCID?